Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 15-21 January 2023 and includes updates on COVID-19, diphtheriae, influenza, Mpox and Cholera.
For 2020, 28 countries reported 1 647 cases of hantavirus infection (0.4 cases per 100 000 population), mainly caused by Puumala virus (98%). During the period 2016–2020, the overall notification rate fluctuated between 0.4 and 1.0 cases per 100 00 population, with no obvious long-term trend.
This issue of the CDTR covers the period 18-24 December 2022 and includes updates on chikungunya, cholera, COVID-19, dengue, C. diphtheriae, Ebola, influenza A(H5N1), Influenza A(H9N2), mass gathering monitoring, Mpox, swine influenza.
This issue of the CDTR covers the period 27 November – 3 December 2022 and includes updates on COVID-19, Ebola, diphtheria, respiratory syncytial virus, seasonal influenza, monkeypox, mass gathering monitoring at the FIFA World Cup 2022 Qatar, Chikungunya, dengue, Shigella sonnei, poliomyelitis, meningitis, cholera.
You may already know about PrEP - the pill one takes to reduce the risk of acquiring HIV. But did you know there is also PEP - the post-exposure prophylaxis - that is used after one may have been exposed to the HIV virus.